Cancer diagnosis in Britain's National Health Service is set to get an AI upgrade, thanks to a Tel Aviv based Ibex Medical Analytics. On Tuesday, Ibex announced its involvement in the UK's first rollout of clinical grade AI applications for cancer detection in pathology.
In recent years, a steady increase in the number of cancer cases has coincided with a world-wide decrease in the number of pathologists, that is, medical workers who examine tissue samples for signs of disease including cancers. In the UK, this shortage of pathologists have led to waiting time for diagnosis of cancers of up to six weeks, placing pressure on pathology services which can lead to missed diagnoses.
